Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 4963-4971

  Qi, Jingsong ^a   Zhao, Peng ^a   Li, Fenbao ^a   Guo, Yingchang ^a   Cui, Hongkai ^a   Liu, Aiguang ^a   Mao, Huajie ^a   Zhao, Yongli ^a   Zhang, Xizhong ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cell polarization; Hepatocellular carcinoma cells; Interventional therapy; Rab17; Signaling pathway; Small GTPase

Indexed keywords

ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RAB PROTEIN; RAB17 PROTEIN, EPITHELIAL;

ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA, HEPATOCELLULAR; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LIVER NEOPLASMS; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE; TUMOR INVASION; TUMOR VOLUME; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASE INHIBITORS; RAB GTP-BINDING PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84937827749     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goni S, Santamaria M, Prieto J and Avila MA. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 2009; 234: 713-725.
2. Bruix J and Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
3. Llovet JM, Burroughs A and Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
4. Llovet JM and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442.
5. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, screening. Semin Liver Dis 2005; 25: 143-154.
6. El-Serag HB and Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
7. Kremsdorf D, Soussan P, Paterlini-Brechot P and Brechot C. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 2006; 25: 3823-3833.
8. Lupberger J and Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007; 13: 74-81.
9. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669.
10. Markiewski MM, De Angelis RA and Lambris JD. Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes? Mol Immunol 2006; 43: 45-56.
11. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D and Bruix J. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
12. Agarwal R, Jurisica I, Mills GB and Cheng KW. The emerging role of the RAB25 small GTPase in cancer. Traffic 2009; 10: 1561-1568.
13. Cheng KW, Lahad JP, Gray JW and Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 2005; 65: 2516-2519.
14. Mitra S, Cheng KW and Mills GB. Rab25 in cancer: a brief update. Biochem Soc Trans 2012; 40: 1404-1408.
15. Liu YJ, Wang Q, Li W, Huang XH, Zhen MC, Huang SH, Chen LZ, Xue L and Zhang HW. Rab23 is a potential biological target for treating hepatocellular carcinoma. World J Gastroenterol 2007; 13: 1010-1017.
16. McMurtrie EB, Barbosa MD, Zerial M and Kingsmore SF. Rab17 and rab18, small GTPases with specificity for polarized epithelial cells: genetic mapping in the mouse. Genomics 1997; 45: 623-625.
17. Lutcke A, Jansson S, Parton RG, Chavrier P, Valencia A, Huber LA, Lehtonen E and Zerial M. Rab17, a novel small GTPase, is specific for epithelial cells and is induced during cell polarization. J Cell Biol 1993; 121: 553-564.
18. Hunziker W and Peters PJ. Rab17 localizes to recycling endosomes and regulates receptor-mediated transcytosis in epithelial cells. J Biol Chem 1998; 273: 15734-15741.
19. Mori Y, Matsui T, Furutani Y, Yoshihara Y and Fukuda M. Small GTPase Rab17 regulates dendritic morphogenesis and postsynaptic development of hippocampal neurons. J Biol Chem 2012; 287: 8963-8973.
20. von Thun A, Birtwistle M, Kalna G, Grindlay J, Strachan D, Kolch W, von Kriegsheim A and Norman JC. ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin-beta2. J Cell Sci 2012; 125: 1465-1477.
21. Zhang M, Zhang X, Bai CX, Chen J and Wei MQ. Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells. Acta Pharmacol Sin 2004; 25: 61-67.
22. Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, Cao D, Zhang WP, Hu HP and Wang HY. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer 2011; 11: 271.
23. Weidner N, Semple JP, Welch WR and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
24. Marrero JA. Hepatocellular carcinoma. Curr Opin Gastroenterol 2005; 21: 308-312.
25. Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK and Thorgeirsson SS. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 2004; 36: 1306-1311.
26. Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM and Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis and hepatocellular carcinoma. Proc Natl Acad Sci U S A 2005; 102: 3389-3394.
27. Espelt MV, Croci DO, Bacigalupo ML, Carabias P, Manzi M, Elola MT, Munoz MC, Dominici FP, Wolfenstein-Todel C, Rabinovich GA and Troncoso MF. Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization and in vivo tumor growth. Hepatology 2011; 53: 2097-2106.
28. Dong WW, Mou Q, Chen J, Cui JT, Li WM and Xiao WH. Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J Gastroenterol 2012; 18: 1806-1813.
29. You X, Liu F, Zhang T, Li Y, Ye L and Zhang X. Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis 2013; 34: 1644-1652.
30. Satoh Y, Endo S, Ikeda T, Yamada K, Ito M, Kuroki M, Hiramoto T, Imamura O, Kobayashi Y, Watanabe Y, Itohara S and Takishima K. Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. J Neurosci 2007; 27: 10765-10776.
31. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L and Brambilla R. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 2006; 5: 14.
32. Reddy KB, Nabha SM and Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003; 22: 395-403.
33. Ueoka Y, Kato K, Kuriaki Y, Horiuchi S, Terao Y, Nishida J, Ueno H and Wake N. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. Br J Cancer 2000; 82: 891-899.
34. Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS and Mobley WC. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 2003; 39: 69-84.